Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Traws Pharma (TRAW) Preferred Dividend Payments (2024 - 2025)

Traws Pharma (TRAW) has disclosed Preferred Dividend Payments for 4 consecutive years, with -$1.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Preferred Dividend Payments changed N/A to -$1.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$4.2 million, a N/A change, with the full-year FY2024 number at -$111.8 million, changed N/A from a year prior.
  • Preferred Dividend Payments was -$1.4 million for Q3 2025 at Traws Pharma, down from -$692000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $6.4 million in Q1 2025 to a low of -$102.4 million in Q2 2024.